Netherlands· NL-a3acba37bf81

Telmisartan Glenmark 80 mg, Filmomhulde Tabletten

A telmisartan product containing telmisartan, registered in Netherlands by Glenmark Arzneimittel GmbH. The same ATC class is registered in 17 of our 19 countries.

ATC C09CA07

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about telmisartanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Telmisartan is registered in 17 of 19 countries.

Countries holding a registration under ATC C09CA07 (telmisartan), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search telmisartan products by name

Telmisartan · ATC C09CA07

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of telmisartan costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.14 in France to $0.71 in Switzerland — a ×5.0 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Telmisartan · price per daily dose (40 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.71
IT Italy$0.16
US United States$0.15 (acquisition cost)
FR France$0.14

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TELMISARTAN
Manufacturer: Glenmark Arzneimittel GmbH
Country: Netherlands (NL)
ATC code: C09CA07
ATC class: Telmisartan
Defined daily dose: 40 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
106145

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

334 interactions on record for telmisartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check telmisartan against other medicines How interaction checks work

Telmisartan · interactions on record

334 records

7 severe
121 moderate
1 minor
124 info

Most severe, free to view

Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
Potassium gluconateA12BA05severe
Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Telmisartan in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telmisartan products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Actelsar, Telmicard
Belgium · Telmisartan Eg, Telmisartan Teva
Bulgaria · Telsart, Tезео
Cyprus · Telmisartan Jubilant
Czechia · Telmisartan Egis, Telmisartan Ratiopharm
Germany · Telmisartan 1 A Pharma, Telmisartan Abz
Denmark · Telmisartan Medical Valley, Telmisartan Stada
Estonia · Telmisartaan Amarox, Telmisartan Ratiopharm
Spain · Telmark, Telmisartán Almus
Finland · Telmark, Telmisartan Amarox
France · Telmisartan Amarox, Telmisartan Arrow
United Kingdom (Northern Ireland) · Telmisartan Accord Healthcare, Telmisartan Amarox
Hungary · Tanydon, Telmisartan Egis
Ireland · Mirpresoc, Telmisartan Accord Healthcare Ireland
Iceland · Kinzalmono, Micardis
Italy · Telmisartan Almus, Telmisartan Alter
Liechtenstein · Kinzalmono, Micardis
Lithuania · Telmisartan Ingen Pharma, Telmisartan Inteli
Luxembourg · Telmisartan Eg, Telmisartan Micro Labs
Latvia · Telmisartan Ratiopharm, Tezeo
Norway · Kinzalmono, Micardis
Poland · Actelsar, Polsart
Portugal · Diterpris, Mirpresoc
Romania · Tezeo
Sweden · Telmark, Telmisartan Amarox
Slovakia · Telmark, Telmisartan Egis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9ef17c63-63cd-4062-a62a-88a3b84cc998
GET /v1/drugs/9ef17c63-63cd-4062-a62a-88a3b84cc998?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h106145_smpc.pdf",
  "strength": null,
  "atc_label": "Telmisartan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg106145",
  "excipients": [
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MEGLUMINE",
    "NATRIUMHYDROXIDE (E 524)",
    "POVIDON K 25 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "TELMISARTAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h106145.pdf",
  "authorised_at": "2011/11/07",
  "procedure_number": "NL/H/4528/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "106145",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about telmisartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console